Session I : Prophylaxis As the Standard of Care Moderators- Emna Gouider (Tunisia)/ Salim Nekkal (Algeria)
09:00-09:20 |
Regional Overview: Setting the Scene for Prophylaxis in Eastern Mediterranean - Mohammed Hadeel (Kuwait)
|
09:20-09:35 |
Algeria’s Experience inProphylaxis: Successes and Challenges - Naouel Salhi (Algeria)
|
09:35-10:00 |
Panel Discussion
- Claudia Khayat (Lebanon)
- Tahira Zafar (Pakistan)
- Naglaa Shahin (Egypt)
|
10:00-10:40 |
SYMPOSIUM SOBI How to Better Prevent Joint Health. A Major Challenge for Haemophilia A Patients: Joint Health in Children with Hemophilia A - and Added Value of Elocta from International and Turkish Experience
- Ali Bulent Antmen (Turkiye)
- Discussion: Q and A (10 mn)
|
10:40-11:00 |
COFFEE BREAK AND POSTER VISITS
|
Session II : VWD Diagnosis and Treatment:Priorities for the Eastern Mediterranean Region Moderators - Tarek Owaidah(Saudi Arabia ) / Issam Frigaa(Algeria)
11:00-11:15 |
Finding the Patients: Challenges of VWD Diagnosis - K.Guenounou (Algeria)
|
11:15-11:30 |
Syria VWD Initiative: Results to-Date -Tahani Al-Ali (Syria)
|
11:30-11:45 |
Management of VWD: Should We Provide Prophylaxis for Severe Patients? -Magdy El-Ekiaby (Egypt)
|
11:45-12:00 |
Discussion: Q and A
|
12:00-12:40 |
SYMPOSIUM ROCHE Therapeutic Innovation in Hemophilia: It's Now in Algeria
- Reda Messaoudi(Algeria) 15 mn
- Aida Mohand Oussaid (Algeria) 15 mn
- Discussion: Q and A (10 mn)
|
12:40-14:00 |
LUNCH AND PRAYER BREAK
|
Session III : Platelet Disorders in the Eastern Mediterranean Region Moderators - Ahmed Tarawah (Saudi Arabia)/ Reda Messaoudi (Algeria)
14:00-14:30 |
State of the Art: Overview of Inherited Platelet Disorders - Barbara Konkle (USA)
|
14:30-15:00 |
Experiences from the Region :
- Egypt experience:Hanan Hamed (Egypt) 10 mn
- Gulf experience: Yasser Wali (Oman) 10 mn
- Tunisian and Algerian Experience: Meriem Achour (Tunisia) 10 mn
|
15:00-15:15 |
Discussion: Q and A
|
15:20-16:00 |
SYMPOSIUM NOVO NORDISK Moderator : Nemra Mehalhal ( Algeria ) Advancing Haemophilia Care: Insights FromOngoing Clinical Trials on Anti-TFPI Therapy
- Meriem Bensadok (Algeria) 30 mn
- Discussion: Q and A (10 mn)
|
16:00-16:20 |
COFFEE BREAK AND POSTER VISITS
|
SESSION IV : Outreach, diagnosis and treatment for women and girls with bleeding disorders Moderators: Tahira Zafar (Pakistan) / Nidhal Rahhal (Iraq)
16:20-16:30 |
Scene Setting: WFH Overview–RanaSaifi (Regional Manager, Middle East)
|
16:30-17:00 |
Panel Discussion
- Anis Fadhlaoui (Tunisia)
- Nawal Al-Tayyeb (Sudan)
- Jamal Al-Shareef (Libya)
- Mustapha Al-Falah (Jordan)
- Latifa Lamhene (Algeria)
|
17:00-18:00 |
SYMPOSIUM CSL BEHRING Moderator : Rachida Boukari (Algeria) Local and International Experience in Rare Bleeding Disorders: What We Can Learn?
- ATreatment Experience with VWF/FVIII Concentrate: 40 + Years' Experience
– Madlen Reschke (Germany) 20 mne)
- Diagnosis and Management of Congenital Fibrinogen Deficiency
- Claudia Khayat (Lebanon) 20 mn
- Discussion: Q and A (10 mn)
|
20:00-22:00 |
DINNER
|